On Tuesday, Viking Therapeutics, Inc. (NASDAQ:VKTX) highlighted the final results from its VOYAGE Phase 2b trial of VK2809 in patients with biopsy-confirmed non-alcoholic steatohepatitis (NASH, also ...

Viking Therapeutics Inc. VKTX announced on Wednesday that it has initiated a Phase 1 trial evaluating VK3019, an ...

Just call it history revisited. Viking is setting sail again in China. The Viking Yi Dun completed her first voyage from Shanghai to Hong Kong (Shenzhen). Viking’s new itineraries include a domestic ...

Results from VENTURE Phase 2 Study of Subcutaneous VK2735 in Obese Patients and Phase 1 Trial of Oral VK2735 in Healthy Subjects to be Presented SAN DIEGO, Oct. 28, 2024 /PRNewswire/ -- Viking ...

Viking Becomes Main Sponsor for the National Team Academy and Norway’s U-Level National Teams “We believe Norwegian football is entering a new golden age, and we are pleased to be part of the journey.

First, a bit of detail about these products and potential products. Lilly's drugs -- Mounjaro and Zepbound -- involve the molecule tirzepatide, which acts on glucagon-like peptide-1 (GLP-1) and ...

Ligand Pharmaceuticals delivered notice to Viking Therapeutics that it was terminating the TR-Beta Program. Ligand said it was terminating the program as a result of its claim that Viking "materially ...